ENVB Stock Summary and Trading Ideas (Enveric Biosciences | NASDAQ:ENVB)

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

Enveric Biosciences trades on the NASDAQ stock market under the symbol ENVB.

As of October 23, 2026, ENVB stock price declined to $1.40 with 24,230 million shares trading.

ENVB has a beta of 0.09, meaning it tends to be less sensitive to market movements. ENVB has a correlation of 0.00 to the broad based SPY ETF.

ENVB has a market cap of $6.27 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ENVB traded as high as $525.60 and as low as $1.17.

The top ETF exchange traded funds that ENVB belongs to (by Net Assets): PSIL, VXF.

ENVB has underperformed the market in the last year with a price return of -82.5% while the SPY ETF gained +15.0%. However, in the short term, ENVB had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.5% vs +2.0% return in SPY. But in the last 2 weeks, ENVB shares have been beat by the market, returning -7.9% compared to an SPY return of -1.8%.

ENVB support price is $1.39 and resistance is $1.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENVB shares will trade within this expected range on the day.